Skip to main content
Clinical Trials/NCT02085525
NCT02085525WithdrawnNot Applicable

A Randomized Comparative Study of a Weekly Versus Every Other Week Nurse Practitioner-led Symptom Management Clinic for Head and Neck Cancer Patients Undergoing Concurrent Chemotherapy and Radiation

University of Michigan Rogel Cancer Center1 site in 1 countryStarted: March 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Locations
1
Primary Endpoint
Percentage of Patients that Experience a "Problem" during Cancer Treatment

Study Overview

Brief Summary

A retrospective chart review of patients receiving concurrent chemoradiotherapy for oropharynx cancer was performed to compare clinical data for patients treated prior to the initiation of the NP clinic with those subsequently seen weekly in the NP clinic. The variables studied included; rate of hospitalization, dose completion and dose reductions. The results revealed an overall improvement in all variables for those patients seen in the weekly NP clinic.

To further analyze this data a randomized, prospective study is proposed to validate the findings of the retrospective study. It is predicted that a weekly NP led clinic will decrease costly hospitalizations, increase patient treatment completion and improve overall patient quality of life and satisfaction.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Have a diagnosis of stage III or IV HNC
  • •Are initiating concurrent chemotherapy and radiation
  • •Are able and willing to sign informed consent
  • •Ages 18 years or older
  • •ECOG (Eastern Cooperative Oncology Group) score of 0 or 1 (The ECOG score attempt to quantify cancer patients' general well-being and activities of daily life)
  • •Able to read and complete the required survey

Exclusion Criteria

  • •Cannot provided informed consent
  • •Any medical or psychiatric illness which in the opinion of the principal investigator would compromise the patient's ability to tolerate this treatment.
  • •Have a history of prior cancer within past 5 years (excluding non-melanoma skin cancer)
  • •Are unwilling or unable to complete the required QOL (Quality of Life) survey

Arms & Interventions

Weekly NP Visits

Other

100 HNC (Head and Neck Cancer) patients seen weekly in a Nurse Practitioner (NP) led symptom management clinic for supportive care.

Intervention: Nurse Practitioner Clinic (Other)

Every Other Week NP Visits

Other

100 HNC (Head and Neck Cancer) patients seen every other week in a Nurse Practitioner (NP) led symptom management clinic for supportive care.

Intervention: Nurse Practitioner Clinic (Other)

Outcomes

Primary Outcomes

Percentage of Patients that Experience a "Problem" during Cancer Treatment

Time Frame: 11 weeks

A "problem" includes any one of three events: dose reduction, inability to complete treatment, or toxicity related hospitalization. Patients are assigned a 1 if any of these events occurs at least once during treatment or are assigned 0 if they complete treatment with no dose reductions or toxicity related hospitalizations. When data is analyzed and reported, the problem rate will be summarized along with the each individual negative component.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials